ARTICLE | Financial News
Cyteir raises $29M series B
March 8, 2018 7:51 PM UTC
Cyteir Therapeutics Inc. (Cambridge, Mass.) raised $29 million in a series B round led by Venrock. Existing investor Celgene Corp. (NASDAQ:CELG) participated alongside new investors Lightstone Ventures and DROIA Oncology Ventures.
Cyteir plans to begin clinical studies next year of its small molecule inhibitors of RAD51 homolog (RAD51) in cancer indications. ...
BCIQ Company Profiles